Vir Biotechnology, Inc. (VIR)
8.505
+0.06
(+0.65%)
USD |
NASDAQ |
Jun 09, 16:00
8.21
-0.30
(-3.47%)
After-Hours: 19:33
Vir Biotechnology SG&A Expense (Quarterly) : 23.34M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 28.24M |
| Revolution Medicines, Inc. | 101.25M |
| Kymera Therapeutics, Inc. | 20.36M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |